Clemens Weber

VALIANT: The Visual Abstract — NephJC The VALIANT phase 3 RCT shows that proximal C3 inhibition with pegcetacoplan leads to a significantly greater reduction in proteinuria compared with placebo in patients with C3G and primary immune-com...

Check out the VA for VALIANT from @nephromommy-akshu.bsky.social
#NephJC
www.nephjc.com/news/2026/1/11/valiant-the-visual-abstract

Top Stories in Nephrology 2025 — NephJC 2025 was rich in successful stories. Here are the top 10 that impressed our audience.

It's 2026!🎉
We will be counting down the Top Ten Nephrology Stories of 2025 on 1/6/26 at 9 pm EST.
Join us on TWITTER (it will always be Twitter to us).
Come on by #NephJC faithful for a lively discussion! You picked & we're count'em down.
www.nephjc.com/news/2025/1/3/top-stories-in-nephrology-2025

1/10

Last #NephJC we discussed dialysis frequency in AKI-D #TenPostNephJC

We sought to answer an age-old question: Is less is really more? Or less is just simply what it is….less?

pubmed.ncbi.nlm.nih.gov/41201895/

Fish Oil in Dialysis: A Big Catch or an Empty Net — NephJC Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?

Maybe the most shocking study from #KidneyWk.
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil

Clemens Weber. No COI other than the fact that i always misspell Atacicept.

Clemens Weber, no COI.

#NephJC

KDIGO 2025 IgA guidelines - Visual Abstract — NephJC KDIGO 2025 is here. IgAN management is evolving with precision risk tools, new therapies, and a stronger focus on kidney protection. Check out the visual abstract created by Natalia Nombera

⏩ Next #NephJC is on IgA nephropathy @kdigo.org guideline

🎨 Nice visual summary by @roxnonna23.bsky.social

www.nephjc.com/news/2025/10...

a fish is looking at a bowl of food with the words " going to get some food " above it ALT: a fish is looking at a bowl of food with the words " going to get some food " above it

Hey there. Clemens Weber checking in from Vacation in Scotland where we just had a ton of fish, so probably too much protein!

No COI

#NephJC

The Protein Pendulum in CKD: supplement or restrict? — NephJC This week, we will discuss an old dilemma in nephrology. To restrict or supplement the proteins? Premise: advanced CKD and dialysis.

🗓️Join us 10/14/25 as we discuss:
Are you team PRO protein 💪 or team RESTRICT protein 🥗
The strategies seem to shift somewhat as CKD progresses to ESRD. What's the evidence say 🤔?
🕰️9pm EST only on Bluesky. #NephSky #MedSky
www.nephjc.com/news/proteins-eskd

Protein supplementation in CKD: The Visual Abstract — NephJC We like protein, or do we? Low protein, high protein, supplements…what’s a nephrologist to do?

Check at the VA for our discussion of protein diet strategies by @msocomd.bsky.social. Is restricting protein in CKD and pushing protein in ESRD #TWDFNR?

www.nephjc.com/news/2025/10...

a man in a white shirt is looking at another man and says how are you alive ALT: a man in a white shirt is looking at another man and says how are you alive

I had one of those on AZA from the early eighties seemed absolutely unreal
#NephJC

Same here, close to no steroid-free regiments.
#NephJC

Clemens Weber. No COI other than working at a transplant center with a very careful immunosuppression reduction strategy.
#NephJC

NephJC 2025 Fall Pledge Drive — NephJC Help keep NephJC a vital, original, and unbiased source of medical education.

It’s that time of the year!

www.nephjc.com/news/2025/9/...

#NephJC

How does it feel? I am on night shift so awake anyway 😅

Hey, joining late to the party. No COI. Got a lot to catch up on. #NephJC

PREVENT, Detect, Treat: What’s New in the 2025 Hypertension Toolkit — NephJC This week, we will discuss the AHA/ACC 2025 hypertension guideline update. Wow, have eight years flown by?

Change is in the Autumn air 🌬️🍂
Join use only on #Bluesky on 9/16/25 at 9pm EST.
We're discussing the 2025 ACC/AHA Hypertension Guideline Update. 🫀🫘🧠 #NephSky #MedSky
www.nephjc.com/news/accaha2025-klno3

In ESRD is spironolactone an overACHIEVEr? — NephJC This week, we will discuss the ACHIEVE trial. Will spironolactone achieve CV benefits in ESRD?

Join us 9/2/25 at 9pm EST.
We will discuss the use of spironolactone in patients on dialysis to prevent t cardiovascular outcomes and heart failure hospitalizations.
Invite your friends. #NephJC #NephSky

www.nephjc.com/news/achieve

Last #NephJC we discussed the significance and causes of eGFRdiff, the difference between eGFR creatinine and cystatin C (eGFRdiff= eGFRcys-eGFRcr)

#TenPostNephJC #NephSky

Read the article 👇
pubmed.ncbi.nlm.nih.gov/40373998/

That’s were we will see more issues outside of the trial setting i believe.
#NephJC

a dog is sitting on a couch with its eyes closed and a person standing behind it . ALT: a dog is sitting on a couch with its eyes closed and a person standing behind it .

currently 3am

#NephJC
Clemens Weber
No COI

NephJC Shorts: Salt reduction still lowers BP  — NephJC JAMA 2023 Dec 19;330(23):2258-2266 doi: 10.1001/jama.2023.23651. Effect of Dietary Sodium on Blood Pressure: A Crossover Trial Deepak K Gupta ,  Cora E Lewis ,  Krista A Varady ,&nbsp...

🆕 #NephJCshort by @hswapnil.medsky.social on CARDIA SSBP trial @jama.com

🧂Shaking up an old rule: does less salt still mean less pressure?

#medsky #nephsky

www.nephjc.com/news/2025/6/...

NephJC interns

The class of 2025, #NephJC interns

www.nephjc.com/news/2025/6/...

Welcome next #NephJC generation! New NephJC authors & creators debuting in July 2025, check them out & give them a follow! 📸
Team A:
@sejalplakhani.bsky.social
@notjustdialysis.bsky.social
@msocomd.bsky.social
@shelliefravel.bsky.social
@salinesolut.bsky.social
@jeyakimarmeyyappan.bsky.social

The #NephJC is starting ! Welcome everyone ! 🎊 @nephjc.bsky.social @kireports.bsky.social